COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company, has scheduled its fourth quarter and full year 2024 financial results announcement for Wednesday, March 26, 2025, before U.S. markets open.
The company will host a conference call at 10:00 a.m. EST to discuss financial results and corporate updates. Investors can participate using the following dial-in numbers:
- U.S. investors: 1-877-407-9716
- International investors: 1-201-493-6779
- Israel investors: 1-809-406-247
CollPlant Biotechnologies (NASDAQ: CLGN), un'azienda nel campo della medicina rigenerativa e estetica, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per mercoledì 26 marzo 2025, prima dell'apertura dei mercati statunitensi.
L'azienda ospiterà una conferenza telefonica alle 10:00 EST per discutere i risultati finanziari e gli aggiornamenti aziendali. Gli investitori possono partecipare utilizzando i seguenti numeri di telefono:
- Investitori statunitensi: 1-877-407-9716
- Investitori internazionali: 1-201-493-6779
- Investitori israeliani: 1-809-406-247
CollPlant Biotechnologies (NASDAQ: CLGN), una empresa de medicina regenerativa y estética, ha programado el anuncio de resultados financieros del cuarto trimestre y del año completo 2024 para miércoles 26 de marzo de 2025, antes de la apertura de los mercados en EE. UU.
La empresa llevará a cabo una conferencia telefónica a las 10:00 a.m. EST para discutir los resultados financieros y las actualizaciones corporativas. Los inversores pueden participar utilizando los siguientes números de acceso:
- Inversores de EE. UU.: 1-877-407-9716
- Inversores internacionales: 1-201-493-6779
- Inversores de Israel: 1-809-406-247
CollPlant Biotechnologies (NASDAQ: CLGN), 재생 및 미용 의학 회사가 2025년 3월 26일 수요일에 2024년 4분기 및 연간 재무 결과 발표를 예정하고 있습니다. 미국 시장 개장 전에 발표됩니다.
회사는 동부 표준시 기준 오전 10시에 재무 결과 및 기업 업데이트에 대해 논의하기 위한 전화 회의를 개최할 것입니다. 투자자들은 다음 전화번호를 사용하여 참여할 수 있습니다:
- 미국 투자자: 1-877-407-9716
- 국제 투자자: 1-201-493-6779
- 이스라엘 투자자: 1-809-406-247
CollPlant Biotechnologies (NASDAQ: CLGN), une entreprise de médecine régénérative et esthétique, a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour mercredi 26 mars 2025, avant l'ouverture des marchés américains.
L'entreprise organisera une conférence téléphonique à 10h00 EST pour discuter des résultats financiers et des mises à jour de l'entreprise. Les investisseurs peuvent participer en utilisant les numéros suivants :
- Investisseurs américains : 1-877-407-9716
- Investisseurs internationaux : 1-201-493-6779
- Investisseurs israéliens : 1-809-406-247
CollPlant Biotechnologies (NASDAQ: CLGN), ein Unternehmen für regenerative und ästhetische Medizin, hat die Bekanntgabe der Finanzzahlen für das vierte Quartal und das gesamte Jahr 2024 für Mittwoch, den 26. März 2025, vor der Eröffnung der US-Märkte angesetzt.
Das Unternehmen wird um 10:00 Uhr EST eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse und Unternehmensupdates zu besprechen. Investoren können über die folgenden Telefonnummern teilnehmen:
- US-Investoren: 1-877-407-9716
- Internationale Investoren: 1-201-493-6779
- Investoren aus Israel: 1-809-406-247
- None.
- None.
Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m.
REHOVOT,

Conference call information
To participate in the conference call, please use the dial-in information below:
U.S. investors: 1-877-407-9716
Investors outside of the
Conference ID: 13750725
Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:
https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6
Webcast information
A live audio only webcast will also be available in listen-only mode and can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.
Submit questions to management in advance of the call
To ask management a question ahead of the call, please email Dan Ferry at LifeSci Advisors, LLC up until 24 hours before the event at daniel@lifesciadvisors.com.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on medical aesthetics and 3D bioprinting of tissues and organs. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com
Contacts
CollPlant: | Investor: |
Eran Rotem | Daniel Ferry |
Deputy CEO & CFO | Managing Director |
Tel: +972-73-2325600 | LifeSci Advisors, LLC |
Email: eran@collplant.com |
Logo - https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information-302405677.html
SOURCE CollPlant